search
Back to results

Restricting the Use of Artesunate Plus Amodiaquine Combination Therapy to Malaria Cases Confirmed by a Dipstick Test: A Cluster Randomised Control Trial (RDT-ACT)

Primary Purpose

Malaria

Status
Completed
Phase
Phase 4
Locations
Ghana
Study Type
Interventional
Intervention
RDT
Clinical Judgement as basis for treatment of malaria with ACT
Sponsored by
Kintampo Health Research Centre, Ghana
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Malaria focused on measuring malaria, rapid diagnostic test, artemisinin, Ghana

Eligibility Criteria

undefined - 48 Months (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • All children aged less than 48mths reporting to health center with suspected malaria

Exclusion Criteria:

  • Children having chronic illnesses such as severe malnutrition and heart disease will be excluded from the study.

Sites / Locations

  • Kintampo Health Research Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

RDT+ACT group

Clinical judgement+ACT group

Arm Description

RDT+ACT group (ACT offered to RDT positive cases only)

Clinical judgement+ACT group (ACT offered to all suspected cases of malaria by clinical judgement)

Outcomes

Primary Outcome Measures

Incidence of malaria (fever + any level of parasite density) in < 48 month-old children (Stage 2, Component A)

Secondary Outcome Measures

Incidence of severe anaemia (Hb <8 g/dl) in < 48 month old children

Full Information

First Posted
January 29, 2009
Last Updated
December 20, 2012
Sponsor
Kintampo Health Research Centre, Ghana
Collaborators
London School of Hygiene and Tropical Medicine
search

1. Study Identification

Unique Protocol Identification Number
NCT00832754
Brief Title
Restricting the Use of Artesunate Plus Amodiaquine Combination Therapy to Malaria Cases Confirmed by a Dipstick Test: A Cluster Randomised Control Trial
Acronym
RDT-ACT
Official Title
Effects of Restricting the Use of AS-AQ Combination Therapy to Malaria Cases Confirmed by a Dipstick Test: A Cluster Randomised Control Trial
Study Type
Interventional

2. Study Status

Record Verification Date
December 2012
Overall Recruitment Status
Completed
Study Start Date
March 2009 (undefined)
Primary Completion Date
August 2012 (Actual)
Study Completion Date
December 2012 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Kintampo Health Research Centre, Ghana
Collaborators
London School of Hygiene and Tropical Medicine

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Effective use of Rapid Diagnostic Test (RDT) and artemisinin-based combination therapy (ACT) depends on the accuracy and safety of RDT based treatment practices and on factors related to the health delivery system. We propose to study the accuracy and safety of RDT based diagnosis and treatment of febrile illness, health system determinants of effective use of RDTs and the public health outcomes of RDT based ACT for malaria.A cluster randomised trial of RDT based versus clinical judgment based treatment of febrile illness on the incidence of malaria in <48 month old children will be conducted. Health Centres will be randomly allocated to RDT based treatment or clinical judgment based treatment arm and children under 2years of age from the catchment area of each health centre will be followed for 2 years. The cost effectiveness of RDT based approach will be compare with the clinical judgement based treatment.
Detailed Description
Two-stage, four component study Stage I - Component A: Accuracy of RDT and the outcome of treatment based on RDT results Primary outcome:What is the sensitivity and specificity of Paracheck cassettes in Ghana to diagnose malaria? Stage 1 - Component B: delivery system determinants of effective RDT based ACT Primary outcome: What are the delivery system determinants of effective RDT based ACT? Stage 2 - Component A: effects of restricted use of ACTs based on RDT results: a randomised controlled trial Primary outcome: Incidence of malaria (fever + any level of parasite density) in < 48 month-old children Stage 2 - component B: Cost effectiveness analysis: Primary outcome:What is the cost effectiveness of RDT based ACT for treatment of children under 4 years compared with ACT based on clinical judgement?

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Malaria
Keywords
malaria, rapid diagnostic test, artemisinin, Ghana

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
3063 (Actual)

8. Arms, Groups, and Interventions

Arm Title
RDT+ACT group
Arm Type
Experimental
Arm Description
RDT+ACT group (ACT offered to RDT positive cases only)
Arm Title
Clinical judgement+ACT group
Arm Type
Active Comparator
Arm Description
Clinical judgement+ACT group (ACT offered to all suspected cases of malaria by clinical judgement)
Intervention Type
Device
Intervention Name(s)
RDT
Intervention Description
Study children attending RDT+ACT HCs with a febrile illness will be tested with an RDT to confirm malaria and treated with ACT only if they have a positive test for malaria parasite. However if there are signs suggestive of other co-morbidities they will be treated with appropriate medicines in addition to AS+AQ.
Intervention Type
Other
Intervention Name(s)
Clinical Judgement as basis for treatment of malaria with ACT
Intervention Description
Study children attending RDT+ACT HCs with a febrile illness will be tested with an RDT to confirm malaria and treated with ACT only if they have a positive test for malaria parasite. However if there are signs suggestive of other co-morbidities they will be treated with appropriate medicines in addition to AS+AQ.
Primary Outcome Measure Information:
Title
Incidence of malaria (fever + any level of parasite density) in < 48 month-old children (Stage 2, Component A)
Time Frame
Three years
Secondary Outcome Measure Information:
Title
Incidence of severe anaemia (Hb <8 g/dl) in < 48 month old children
Time Frame
Three years

10. Eligibility

Sex
All
Maximum Age & Unit of Time
48 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: All children aged less than 48mths reporting to health center with suspected malaria Exclusion Criteria: Children having chronic illnesses such as severe malnutrition and heart disease will be excluded from the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Frank E Baiden
Organizational Affiliation
Kintampo Health Research Center
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jayne Webster
Organizational Affiliation
London School of Hygiene and Tropical Medicine
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Christopher Whitty
Organizational Affiliation
London School of Hygiene and Tropical Medicine
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Seth Owusu-Agyei
Organizational Affiliation
Kintampo Health Research Center
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Daniel Chandramohan
Organizational Affiliation
London School of Hygiene and Tropical Medicine
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jane Bruce
Organizational Affiliation
London School of Hygiene and Tropical Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kintampo Health Research Center
City
Kintampo
State/Province
BAR
ZIP/Postal Code
200
Country
Ghana

12. IPD Sharing Statement

Citations:
PubMed Identifier
27695130
Citation
Tawiah T, Hansen KS, Baiden F, Bruce J, Tivura M, Delimini R, Amengo-Etego S, Chandramohan D, Owusu-Agyei S, Webster J. Cost-Effectiveness Analysis of Test-Based versus Presumptive Treatment of Uncomplicated Malaria in Children under Five Years in an Area of High Transmission in Central Ghana. PLoS One. 2016 Oct 3;11(10):e0164055. doi: 10.1371/journal.pone.0164055. eCollection 2016. Erratum In: PLoS One. 2017 Jan 20;12 (1):e0170848.
Results Reference
derived
PubMed Identifier
27055275
Citation
Baiden F, Bruce J, Webster J, Tivura M, Delmini R, Amengo-Etego S, Owusu-Agyei S, Chandramohan D. Effect of Test-Based versus Presumptive Treatment of Malaria in Under-Five Children in Rural Ghana--A Cluster-Randomised Trial. PLoS One. 2016 Apr 7;11(4):e0152960. doi: 10.1371/journal.pone.0152960. eCollection 2016.
Results Reference
derived
PubMed Identifier
22514617
Citation
Baiden F, Webster J, Tivura M, Delimini R, Berko Y, Amenga-Etego S, Agyeman-Budu A, Karikari AB, Bruce J, Owusu-Agyei S, Chandramohan D. Accuracy of rapid tests for malaria and treatment outcomes for malaria and non-malaria cases among under-five children in rural Ghana. PLoS One. 2012;7(4):e34073. doi: 10.1371/journal.pone.0034073. Epub 2012 Apr 13.
Results Reference
derived

Learn more about this trial

Restricting the Use of Artesunate Plus Amodiaquine Combination Therapy to Malaria Cases Confirmed by a Dipstick Test: A Cluster Randomised Control Trial

We'll reach out to this number within 24 hrs